Ziekenhuis Oost-Limburg
Genk, Limburg, 3600, Belgium
NCT Number: NCT05172323
Even with second generation drug eluting stents, rates of target lesion failure (TLF) for aorto-ostial RCA lesions remain high [3yrs TLF 14.2%]. Retrospective studies show that stent underexpansion and geographical stent-ostium mismatch are the main predictors for TLF. Geographical mismatch means that the stent is implanted either too distal (thereby not fully covering the lesion) or too proximal (thereby protruding too much in the aorta and hampering future engagement with guiding catheters). The investigators hypothesize that, pre-procedural 3D CT coronarography to determine the optimal C-arm angle of the X-ray system with the most accurate visualization of the aorto-ostial angle and determination of localization of calcium, could prevent geographical mismatch.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Genk, Limburg, 3600, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A contrast CT-scan of the coronary arteries will be performed and 3D analyzed to determine the best angle for the C-arm during Percutaneous Coronary Intervention (PCI) for stent implantation. Furthermore determining the amount and localization of calcium in the right coronary artery (RCA) and diameter and length of RCA. The use of IVUS will be used to determine the degree of calcium.
Standard of care is angiography guided PCI of the ostium of the RCA. The use of IVUS will be used to determine the degree of calcium.
Time frame: Procedural
Distance between the aorta-ostial junction and the most proximal protruding stent strut (in mm).
Time frame: Procedural
Percentage of patients without geographical mismatch as defined by a fully covered ostium AND a maximal length between the aorta-ostial junction and the most proximal protruding stent struts not more then 3mm
Time frame: Procedural
The percentage of patients who need an additional stent after the final IVUS has shown that the ostium was not fully covered
Time frame: Procedural
Expressed in mL
Time frame: Procedural
Expressed in mGy
Time frame: Procedural
Expressed in minutes
Time frame: Procedural
The predicted MLA by 3DCT will be compared with the MLA prior to stent placement as obtained with IVUS
Time frame: Procedural
Predicted stent diameter and length by 3DCT will be compared with the effectively implanted stent size
Time frame: Procedural
Expressed as the minimal stent area (MSA) determined by IVUS, divided by the reference luminal area in the healthy distal landing zone
Time frame: Procedural
Prediction of calcium modification pre-IVUS compared with IVUS based strategy of calcium modification
Time frame: Procedural
Calcium score as determined by 3DCT will be correlated with the maximum calcium arc on IVUS
Time frame: 30 days after PCI
30 days event rate [death, non-fatal MI, non-fatal stroke, definite or probable stent thrombosis, target lesion failure]
Ziekenhuis Oost-Limburg
Other
Pre-procedural 3D Reconstructed Computer Tomography Versus Angiography Guided Percutaneous Coronary Intervention for Ostial Right Coronary Artery Lesions
Acronym: 3DCT-RCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details